Hikma expands into Canada with acquisition of Teligent sterile injectable assets

Hikma expands into Canada with acquisition of Teligent sterile injectable assets

Bykatherine728

Post Views: 140 Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, today announces that it has agreed to acquire the Canadian assets of Teligent Inc. (Teligent) for $45.75 million. The transaction is expected to be completed before the end of the first quarter of 2022. The acquisition marks Hikma’s expansion into Canada and includes a…